Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Rogers

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
BJU International|September 4, 2025
Reply to 'Comment on Bertini et al.: area deprivation and PSA screening disparities' and 'Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency'Alessandro Bertini, Giuseppe Ottone Cirulli, Alex Stephens, et al.
Urology Practice|December 24, 2025
Incarcerated Patients Present with More Advanced Bladder Cancer Stage: A Statewide AnalysisCarlo Silvani, Alfonso Santangelo, Jack Considine, et al.
World Journal of Urology|April 15, 2026
Cancer-specific mortality differences between radical prostatectomy and radiotherapy after biochemical recurrence: analysis of a health system-wide cohortCarlo Silvani, Alfonso Santangelo, Alex Stephens, et al.
Cancer|December 29, 2025
Impact of the Area Deprivation Index on stage at diagnosis in penile squamous cell carcinoma: A statewide cohort analysisCarlo Silvani, Anna Tylecki, Alfonso Santangelo, et al.
BJUI Compass|July 1, 2026
External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohortCarlo Silvani, Alfonso Santangelo, Alex Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidineWade G Alleman, Ray L Tabios, Gadisetti V R Chandramouli, et al.
World Journal of Urology|June 2, 2025
Socioeconomic disparities and MIBC survival outcome-An analysis of a statewide cohortAlessio Finocchiaro, Anna Tylecki, Alex Stephens, et al.
World Journal of Urology|November 26, 2024
Active surveillance follow-up for prostate cancer: from guidelines to real-world clinical practiceGiuseppe Chiarelli, Alex Stephens, Marco Finati, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 9, 2024
Comparison of patient background between a real-world North American cohort and the Göteborg-2 trialGiuseppe Chiarelli, Matthew Davis, Alex Stephens, et al.
BJU International|January 20, 2026
Area deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer: a statewide analysisCarlo Silvani, Alfonso Santangelo, Jack Considine, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
BJU International|September 4, 2025
Reply to 'Comment on Bertini et al.: area deprivation and PSA screening disparities' and 'Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency'Alessandro Bertini, Giuseppe Ottone Cirulli, Alex Stephens, et al.
Urology Practice|December 24, 2025
Incarcerated Patients Present with More Advanced Bladder Cancer Stage: A Statewide AnalysisCarlo Silvani, Alfonso Santangelo, Jack Considine, et al.
World Journal of Urology|April 15, 2026
Cancer-specific mortality differences between radical prostatectomy and radiotherapy after biochemical recurrence: analysis of a health system-wide cohortCarlo Silvani, Alfonso Santangelo, Alex Stephens, et al.
Cancer|December 29, 2025
Impact of the Area Deprivation Index on stage at diagnosis in penile squamous cell carcinoma: A statewide cohort analysisCarlo Silvani, Anna Tylecki, Alfonso Santangelo, et al.
BJUI Compass|July 1, 2026
External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohortCarlo Silvani, Alfonso Santangelo, Alex Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidineWade G Alleman, Ray L Tabios, Gadisetti V R Chandramouli, et al.
World Journal of Urology|June 2, 2025
Socioeconomic disparities and MIBC survival outcome-An analysis of a statewide cohortAlessio Finocchiaro, Anna Tylecki, Alex Stephens, et al.
World Journal of Urology|November 26, 2024
Active surveillance follow-up for prostate cancer: from guidelines to real-world clinical practiceGiuseppe Chiarelli, Alex Stephens, Marco Finati, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 9, 2024
Comparison of patient background between a real-world North American cohort and the Göteborg-2 trialGiuseppe Chiarelli, Matthew Davis, Alex Stephens, et al.
BJU International|January 20, 2026
Area deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer: a statewide analysisCarlo Silvani, Alfonso Santangelo, Jack Considine, et al.
Pageof 14